 |
| APPZ and MDFZF Interviews Rock! |
|
 Hot Stock to Watch
|
Company: Monster Arts Inc. (OTCQB: APPZ)
|
End of Day:
Price: 0.30
Change (%): + 0 (0.00) 0.00
Volume: 0 |
 |
Wayne Irving II, CEO of Monster Arts, Inc., is Featured in a New Audio Interview at SmallCapVoice.com
AUSTIN, Texas, Aug. 1, 2013 (GLOBE NEWSWIRE) - SmallCapVoice.com, Inc. announced today that a new audio interview with Monster Arts Inc. (OTCQB:APPZ), is now available. The interview can be heard at http://smallcapvoice.com/blog/7-26-13-smallcapvoice-interview-with-monster-arts-inc-appz
Wayne Irving II, CEO of Monster Arts, Inc., called into SmallCapVoice.com to discuss the news for the Company, the business models and markets for their technologies, the goals for APPZ in 2013, and much more.
Another big part of the interview is the work that APPZ does with Text Kills®, a community outreach organization that over the last three years has traveled the country in an effort to spread awareness about the dangers and hazards of distracted driving and cyber-bullying.
Continue Reading
|
 Yesterday's Top Performer
|
Company: Medifocus, Inc. (OTCQX: MDFZF) (TSX-V: MFS)
|
End of Day:
Price: 0.20
Change (%): + 0.01 (5.26)
Volume: 11,000 |
 |
Medifocus develops and commercializes minimally invasive focused heat systems for the treatment of cancerous and benign tumors, and enlarged prostate, medically known as Benign Prostatic Hyperplasia (“BPH”). With the recent acquisition of Prolieve®, Medifocus now owns a revenue generating commercial BPH treatment product targeting the estimated $8 billion BPH drug therapy market and generating cash flow to support the development and commercialization of other catheter based or Adaptive Phased Array (APA) based focused heat systems for targeted thermotherapy of surface, subsurface and deep seated localized and regional cancers.
The Company owns two technology platforms with comprehensive US and international patent protection: 1: The Endo-thermotherapy Platform - from which Prolieve was developed can potentially be used to treat cancers in prostate, rectal, cervical and esophageal, and 2: The Adaptive Phased Array (APA) Microwave Focusing Platform - invented by MIT, licensed to Medifocus, directs precisely focused microwave energy at tumor center to induce shrinkage or eradication of tumors without undue harm to surrounding tissue. The Company’s APA 1000 Breast Cancer Treatment System, developed from the APA technology platform, is currently in pivotal Phase-III clinical trials.
Listen To Audio Interview |
Other Small Cap News
|
Company: Coates International, Ltd. (OTCBB: COTE)
|
Coates International, Ltd. To Merge With A Chinese Manufacturing And Casting Company To Mass Produce The Coates CSRV Natural Gas Industrial Generators And Other CSRV Products For Distribution Throughout The Eastern Hemisphere
WALL TOWNSHIP, N.J., Aug. 2, 2013 /PRNewswire/ -- Coates International, Ltd. (NASDAQ OTCBB: COTE) - Coates International, Ltd. (the "Company") has signed a Letter of Commitment with a Chinese manufacturer and foundry casting company, which also owns coal mining companies in China, plans to mass produce the Coates CSRV industrial natural gas electric power engine generators and other CSRV products for distribution throughout China, UAE, and possibly throughout the Eastern hemisphere.
Continue Reading
|
Company: Applied DNA Sciences (OTCBB: APDN)
|
Nearly Half-Million SigNature DNA-Marked Electronic Components in Circulation
STONY BROOK, NY--(Marketwired - Aug 2, 2013) - Applied DNA Sciences, Inc. (OTCBB: APDN), a provider of DNA-based anti-counterfeiting technology and product authentication solutions, announced today that its SigNature DNA mark has been used to protect nearly 500,000 electronics parts in the combined outcome of its pilots and contracts, an effort driven by the U.S. Defense Logistics Agency ("DLA") against the infiltration of counterfeit electronic parts. Seventeen companies are actively marking microcircuits with SigNature DNA, a requirement set out by DLA for companies providing a class of microcircuits to the Agency. Overall, fifty-one companies are signed or in various stages of negotiation.
Continue Reading |
Market News
|
By Lauren Lyster: Daily Ticker
|
Detroit Goes Begging as Obama Sends Money Overseas
At least one thing seems pretty clear since we learned the Motor City has run out of steam: Uncle Sam will not be offering up any emergency reserves.
Detroit, which has filed for a record-setting 18 billion dollar bankruptcy, will not be getting federal assistance if you believe the rhetoric coming from Washington officials.
This has people debating not just whether or not Detroit should get a bailout (lawmakers coughed up billions for the automakers and banks), but debating more broadly how tax dollars are spent at a time when budgets are tight in general.
Continue Reading
|
By Jason Lange: Reuters
|
U.S. hiring slows in July but jobless rate falls to four-year low
WASHINGTON (Reuters) - U.S. employers slowed their pace of hiring in July but the jobless rate fell anyway, mixed signals that could make the U.S. Federal Reserve more cautious about drawing down its huge economic stimulus program.
The number of jobs outside the farming sector increased by 162,000, the Labor Department said on Friday.
That was below the median forecast in a Reuters poll of 184,000. Compounding that miss, the government also cut its previous estimates for hiring in May and June.
Continue Reading
|
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the "unsubscribe" link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
